FY2028 Earnings Forecast for CLDX Issued By Leerink Partnrs
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) – Research analysts at Leerink Partnrs reduced their FY2028 EPS estimates for shares of Celldex Therapeutics in a research note issued to investors on Thursday, February 27th. Leerink Partnrs analyst T. Smith now anticipates that the biopharmaceutical company will post earnings per share of $0.95 for the year, […]
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) – Research analysts at Leerink Partnrs reduced their FY2028 EPS estimates for shares of Celldex Therapeutics in a research note issued to investors on Thursday, February 27th. Leerink Partnrs analyst T. Smith now anticipates that the biopharmaceutical company will post earnings per share of $0.95 for the year, […]
